A hantavirus outbreak aboard an Atlantic cruise ship has revived Covid-era conspiracies, with posts falsely alleging an old ...

These efforts are early-stage and ongoing and reflect Moderna’s broader responsibility to develop countermeasures against ...

After getting slapped with a surprise refuse-to-file letter signed by former CBER Director Vinay Prasad, Moderna’s flu ...

Inovio Pharmaceuticals and Novavax stocks pare back earlier gains as the rally loses enthusiasm.

Moderna is in the early stages of developing a hantavirus vaccine, though its availability could be years away. Shares are up ~14% in Friday aft ...

Marjorie Taylor Greene and other conservative commentators have claimed that Moderna is developing a hantavirus mRNA vaccine.

Shares of Moderna ( MRNA) were up nearly 7% in recent trading, following a 12% jump Friday, after Bloomberg reported the ...

Moderna stock rose 4% on Monday, extending its 12% rally on Friday. What’s behind the move: The biotech is researching ...

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.

RSV and flu mRNA vaccines struggle with lower durability, higher side effects, and weak uptake, leading to program cuts and ...

Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing ...

Moderna (NASDAQ:MRNA) shares climbed 10% on Thursday as concerns mounted over a hantavirus outbreak connected to a cruise ship.